Results 1 to 10 of about 1,772,404 (331)
Correction to "PRMT9 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating PI3K/Akt/GSK-3β/Snail Signaling". [PDF]
Cancer Scieuropepmc +1 more source
Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre study.
World J TransplantGaras MG +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
The Lancet, 2022
Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. Although viral hepatitis and alcohol remain important risk factors, non-alcoholic fatty liver disease is rapidly becoming a dominant cause of hepatocellular carcinoma.
Vogel, Arndt +4 more
semanticscholar +6 more sources
Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. Although viral hepatitis and alcohol remain important risk factors, non-alcoholic fatty liver disease is rapidly becoming a dominant cause of hepatocellular carcinoma.
Vogel, Arndt +4 more
semanticscholar +6 more sources
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021Liver cancer, more specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death and its incidence is increasing globally. Around 50% of patients with HCC receive systemic therapies, traditionally sorafenib or lenvatinib in the first line and regorafenib, cabozantinib or ramucirumab in the second line.
David J. Pinato +10 more
openaire +4 more sources
New England Journal of Medicine, 2019
Presenting the most up-to-date knowledge of hepatocellular carcinoma, it covers all topics — including those more controversial ones — in this rapidly advancing field, from epidemiology to prevention, from molecular biology to gross pathology, from ...
Silvestre R, Duran, Robert D B, Jaquiss
semanticscholar +7 more sources
Presenting the most up-to-date knowledge of hepatocellular carcinoma, it covers all topics — including those more controversial ones — in this rapidly advancing field, from epidemiology to prevention, from molecular biology to gross pathology, from ...
Silvestre R, Duran, Robert D B, Jaquiss
semanticscholar +7 more sources
New England Journal of Medicine, 2012
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended. Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by
Emmanuel A, Tsochatzis +2 more
+12 more sources
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended. Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by
Emmanuel A, Tsochatzis +2 more
+12 more sources
Management of Hepatocellular Carcinoma: A Review.
JAMA Surgery, 2023Importance Hepatocellular carcinoma (HCC) is the sixth most common malignancy and fourth leading cause of cancer-related death worldwide. Recent advances in systemic and locoregional therapies have led to changes in many guidelines regarding systemic ...
Zachary J. Brown +6 more
semanticscholar +1 more source
Global epidemiology and genetics of hepatocellular carcinoma.
Gastroenterology, 2023Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC develops in genetically susceptible individuals who are exposed to risk factors especially in the presence of liver cirrhosis.
M. Toh +6 more
semanticscholar +1 more source